RedHill Biopharma Provides Full-Year 2019 Financial Results and Operational Highlights

Ads

You May Also Like

Celyad announces new agreements with Celdara Medical and Dartmouth College

Ongoing clinical trial development boosts Celyad’s confidence in the future of its oncology assetsCelyad ...

Biocartis Group NV: Results of the extraordinary shareholders’ meeting held on 11 September 2017

PRESS RELEASE: REGULATED INFORMATION11 September 2017, 17:40 CEST                                                            Results of the extraordinary shareholders' meeting ...